Arkema's Shares Drop 1.92% to €61.45 Three Days Before the General Meeting
The specialty chemicals company loses 1.92% to €61.45 at midday on this Monday, May 18, 2026, amidst a SBF 120 decline of 0.72% and a CAC 40 drop of 0.76%. The stock retreats in a market weighed down by Brent crude soaring above $110 and persistent pressure on long-term rates. The session occurs just three days before the shareholders' general meeting.
The Stock Falls Below its MM20 but Remains Well Above its Long-Term Averages
Arkema's share price has fallen below its 20-day moving average, located at €62.55, with a gap of -1.76%. However, the stock still remains above its MM50 (€58.91, a gap of +4.31%) and well above its MM200 (€56.04, a gap of +9.65%). Despite today's setback, the medium and long-term configuration remains bullish.
In the Bollinger Bands, the price is in the lower part, at 23% of the width, between a lower bound at €60.55 and an upper bound at €64.54. The RSI at 53 indicates a market without directional excess. The support threshold identified at €57.65 remains distant, while the resistance at €65.20 was tested last week before the stock receded.
Pressure on Long-Term Rates and Brent at $110 Weigh on Cyclical Stocks
The European session unfolds against a backdrop of a global bond rout: the yield on the US 10-year Treasury climbs to 4.63%, its highest since February 2025, and the Japanese 30-year JGB hits a record around 4.20%. Concurrently, Brent trades above $110, fueling fears of sustained energy inflation. This dual movement weighs on cyclical assets sensitive to energy costs and financing.
As a reminder, during the publication of the Q1 2026 results on May 6, EBITDA had fallen by 14% to 283 million euros, impacted by an unfavorable exchange rate effect and weakness in Advanced Materials. The group had then reaffirmed its target of slight EBITDA growth at constant exchange rates for the year. Shareholders are convened for the general meeting on May 21, the next significant date on the calendar.